Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3710)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
521
Price
$574.71
Total Value
$299.42K
Shares Held After
41,016
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
567
Price
$573.38
Total Value
$325.11K
Shares Held After
41,537
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,688
Price
$572.60
Total Value
$2.11M
Shares Held After
42,104
% of Holdings
8.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,921
Price
$571.59
Total Value
$1.67M
Shares Held After
45,792
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,055
Price
$570.76
Total Value
$602.16K
Shares Held After
48,713
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
245
Price
$569.62
Total Value
$139.56K
Shares Held After
49,768
% of Holdings
0.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
21
Price
$169.56
Total Value
$3.56K
Shares Held After
9,666
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
54
Price
$168.43
Total Value
$9.10K
Shares Held After
9,687
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
373
Price
$167.37
Total Value
$62.43K
Shares Held After
9,741
% of Holdings
3.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
127
Price
$166.56
Total Value
$21.15K
Shares Held After
10,114
% of Holdings
1.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
158
Price
$165.38
Total Value
$26.13K
Shares Held After
10,241
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
267
Price
$164.47
Total Value
$43.91K
Shares Held After
10,399
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$576.62
Total Value
$69.19K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
535
Price
$574.79
Total Value
$307.51K
Shares Held After
19,360
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
321
Price
$573.51
Total Value
$184.10K
Shares Held After
19,895
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,976
Price
$572.66
Total Value
$2.28M
Shares Held After
20,216
% of Holdings
16.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,325
Price
$571.64
Total Value
$1.90M
Shares Held After
24,192
% of Holdings
12.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,079
Price
$570.82
Total Value
$615.91K
Shares Held After
27,517
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
280
Price
$569.63
Total Value
$159.50K
Shares Held After
28,596
% of Holdings
1.0%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
388,067
% of Holdings
0.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
56,450
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
156,869
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
66,083
% of Holdings
0.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.90
Total Value
$49.00K
Shares Held After
3,052,000
% of Holdings
0.3%
Showing 3051–3100 of 3710 transactions (page 62 of 75)